Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Alterations in GATA1s Chromatin Occupancy Lead to Hyperproliferative, Cytokine-Independent Megakaryopoiesis

Kaoru Takasaki, Kristin Murphy, Eric K. Wafula, Christopher S. Thom, Sara S. Kumar, Ying Ting Sit, Alyssa Gagne, Deborah L. French, Laurie A. Steiner, Stella T. Chou

Blood (2024) 144 (Supplement 1): 1170.

https://doi.org/10.1182/blood-2024-211769

Published: 2024

Journal Articles

Single-Cell Transcriptomics Reveal Altered Hematopoietic Mechanisms Driven By T21 and GATA1s

Kaoru Takasaki, Christopher S. Thom, David Smith, Sara S. Kumar, Ying Ting Sit, Alyssa Gagne, Deborah L. French, Stella T. Chou

Blood (2023) 142 (Supplement 1): 2685.

https://doi.org/10.1182/blood-2023-185278

Published: 2023

Journal Articles

Design Characteristics and Risk of Bias of Pivotal Trials Supporting Approval of Hematological Drugs By FDA, 2008-2022: Cross Sectional Analysis

Sara Khan, Aruba Sohail, Maryum Hassan, Janta Ukrani, Areej Fatima, Muhammad Farooq, Kapisthalam S. Kumar

Blood (2023) 142 (Supplement 1): 3695.

https://doi.org/10.1182/blood-2023-183089

Published: 2023

Journal Articles

A 10 Year Analysis of Gender Distribution in National Institutes of Health Funding for Non-Malignant Hematology

Sara Khan, Faraz Eshaghi, Aruba Sohail, Kainat Khan, Taha Huda, Evan Lindbergh, Kapisthalam S. Kumar

Blood (2023) 142 (Supplement 1): 5113.

https://doi.org/10.1182/blood-2023-180317

Published: 2023

Journal Articles

Safety and Feasibility of Outpatient High-Dose Cytarabine Consolidation in AML Patients

Allyson Waller, Shelly Brown, Tracelyn Freeman, Pooja S. Kumar, Alice S. Mims

Blood (2022) 140 (Supplement 1): 5086–5087.

https://doi.org/10.1182/blood-2022-170435

Published: 2022

Journal Articles

Evaluation of the Incidence and Risk Factors Associated with Bleeding Events in Patients Receiving Acalabrutinib Therapy

Pooja S. Kumar, Tracy Wiczer, Lindsay Rosen, Arthur J. Pollauf, Amy Zheng, Marilly Palettas, Leylah Azali, Seema A Bhat, John C. Byrd, Kerry Rogers, Jennifer A. Woyach, Adam S Kittai

Blood (2021) 138 (Supplement 1): 3729.

https://doi.org/10.1182/blood-2021-148719

Published: 2021

Journal Articles

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome

Madhu S. Kumar, Anupama Narla, Atsushi Nonami, Ann Mullally, Nadya Dimitrova, Brian Ball, J. Randall McAuley, Luke Poveromo, Jeffrey L. Kutok, Naomi Galili, Azra Raza, Eyal Attar, D. Gary Gilliland, Tyler Jacks, Benjamin L. Ebert

Blood (2011) 118 (17): 4666–4673.

https://doi.org/10.1182/blood-2010-12-324715

Published: 2011

Includes: Supplemental data

Journal Articles

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

Bart Barlogie, Frits van Rhee, John D. Shaughnessy, Jr, Joshua Epstein, Shmuel Yaccoby, Mauricio Pineda-Roman, Klaus Hollmig, Yazan Alsayed, Antje Hoering, Jackie Szymonifka, Elias Anaissie, Nathan Petty, Naveen S. Kumar, Geetika Srivastava, Bonnie Jenkins, John Crowley, Jerome B. Zeldis

Blood (2008) 112 (8): 3122–3125.

https://doi.org/10.1182/blood-2008-06-164228

Published: 2008

Journal Articles

Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas

DW Kingma, WB Weiss, ES Jaffe, S Kumar, K Frekko, M Raffeld

Blood (1996) 88 (1): 242–251.

https://doi.org/10.1182/blood.V88.1.242.242

Published: 1996

Journal Articles

Lymphoproliferative disorder after immunosuppressive therapy for aplastic anemia [letter]

S Kumar, JB Alperin, D Kumar, WC Pugh

Blood (1994) 83 (6): 1706.

https://doi.org/10.1182/blood.V83.6.1706a.1706a

Published: 1994

Journal Articles

T-cell antigenic sites of the malaria circumsporozoite protein

MF Good, S Kumar, WR Weiss, LH Miller

Blood (1989) 74 (3): 895–900.

https://doi.org/10.1182/blood.V74.3.895.895

Published: 1989

NARROW

Alterations in GATA1s Chromatin Occupancy Lead to Hyperproliferative, Cytokine-Independent Megakaryopoiesis

Single-Cell Transcriptomics Reveal Altered Hematopoietic Mechanisms Driven By T21 and GATA1s

Design Characteristics and Risk of Bias of Pivotal Trials Supporting Approval of Hematological Drugs By FDA, 2008-2022: Cross Sectional Analysis

A 10 Year Analysis of Gender Distribution in National Institutes of Health Funding for Non-Malignant Hematology

Safety and Feasibility of Outpatient High-Dose Cytarabine Consolidation in AML Patients

Evaluation of the Incidence and Risk Factors Associated with Bleeding Events in Patients Receiving Acalabrutinib Therapy

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas

Lymphoproliferative disorder after immunosuppressive therapy for aplastic anemia [letter]

T-cell antigenic sites of the malaria circumsporozoite protein

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only